SG Americas Securities
GLSI icon

SG Americas Securities’s Greenwich LifeSciences GLSI Stock Holding History

SG Americas Securities’s Portfolio GLSI Stock Details GLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,395
Closed -$107K – 3148
2021
Q4 		$107K Buy
+4,395
New +$147K ﹤0.01% 3053

Other funds holding GLSI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

SG Americas Securities's GLSI Position: Q1 2022 in Review

SG Americas Securities sold out of Greenwich LifeSciences (GLSI) in Q1 2022, closing a stake of 4,395 shares — an estimated $107K sold.

SG Americas Securities first reported a position in GLSI in Q4 2021 and held it in 1 quarter. The position peaked at $107K in Q4 2021. 34 funds tracked by Wall St. Rank hold GLSI as of Q1 2022.

  • SG Americas Securities reported no remaining Greenwich LifeSciences position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 4,395 Greenwich LifeSciences shares in Q1 2022, an estimated $107K.
  • SG Americas Securities first reported a position in Greenwich LifeSciences in Q4 2021 and held it in 1 quarter.
  • SG Americas Securities's Greenwich LifeSciences position peaked at $107K in Q4 2021.
  • 34 funds tracked by Wall St. Rank held Greenwich LifeSciences as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.